Result Number | Material Type | Add to My Shelf Action | Record Details and Options |
---|---|---|---|
1 |
Material Type: Artigo
|
Immune-related toxicities of checkpoint inhibitors: mechanisms and mitigation strategiesSullivan, Ryan J ; Weber, Jeffrey SNature reviews. Drug discovery, 2022-07, Vol.21 (7), p.495-508 [Periódico revisado por pares]London: Nature Publishing GroupTexto completo disponível |
|
2 |
Material Type: Artigo
|
PD-1 and PD-L1 antibodies in cancer: current status and future directionsBalar, Arjun Vasant ; Weber, Jeffrey S.Cancer Immunology, Immunotherapy, 2017-05, Vol.66 (5), p.551-564 [Periódico revisado por pares]Berlin/Heidelberg: Springer Berlin HeidelbergTexto completo disponível |
|
3 |
Material Type: Artigo
|
Solid Lipid Nanoparticles (SLN) and Nanostructured Lipid Carriers (NLC) for pulmonary application: A review of the state of the artWeber, S. ; Zimmer, A. ; Pardeike, J.European journal of pharmaceutics and biopharmaceutics, 2014-01, Vol.86 (1), p.7-22 [Periódico revisado por pares]Netherlands: Elsevier B.VTexto completo disponível |
|
4 |
Material Type: Artigo
|
Management of Immune-Related Adverse Events and Kinetics of Response With IpilimumabWeber, Jeffrey S ; Kähler, Katharina C ; Hauschild, AxelJournal of clinical oncology, 2012-07, Vol.30 (21), p.2691-2697 [Periódico revisado por pares]Alexandria, VA: American Society of Clinical OncologyTexto completo disponível |
|
5 |
Material Type: Artigo
|
Toxicities of Immunotherapy for the PractitionerWeber, Jeffrey S ; Yang, James C ; Atkins, Michael B ; Disis, Mary LJournal of clinical oncology, 2015-06, Vol.33 (18), p.2092-2099 [Periódico revisado por pares]United States: American Society of Clinical OncologyTexto completo disponível |
|
6 |
Material Type: Artigo
|
Pooled Analysis of Long-Term Survival Data From Phase II and Phase III Trials of Ipilimumab in Unresectable or Metastatic MelanomaSchadendorf, Dirk ; Hodi, F Stephen ; Robert, Caroline ; Weber, Jeffrey S ; Margolin, Kim ; Hamid, Omid ; Patt, Debra ; Chen, Tai-Tsang ; Berman, David M ; Wolchok, Jedd DJournal of clinical oncology, 2015-06, Vol.33 (17), p.1889-1894 [Periódico revisado por pares]United States: American Society of Clinical OncologyTexto completo disponível |
|
7 |
Material Type: Artigo
|
The Role of B Cells and Antibodies in Multiple Sclerosis, Neuromyelitis Optica, and Related DisordersHäusser-Kinzel, Silke ; Weber, Martin SFrontiers in immunology, 2019-02, Vol.10, p.201-201 [Periódico revisado por pares]Switzerland: Frontiers Media S.ATexto completo disponível |
|
8 |
Material Type: Artigo
|
Placebo-Controlled Trial of an Oral BTK Inhibitor in Multiple SclerosisMontalban, Xavier ; Arnold, Douglas L ; Weber, Martin S ; Staikov, Ivan ; Piasecka-Stryczynska, Karolina ; Willmer, Jonathan ; Martin, Emily C ; Dangond, Fernando ; Syed, Sana ; Wolinsky, Jerry SThe New England journal of medicine, 2019-06, Vol.380 (25), p.2406-2417 [Periódico revisado por pares]United States: Massachusetts Medical SocietyTexto completo disponível |
|
9 |
Material Type: Artigo
|
Gray Mold Populations in German Strawberry Fields Are Resistant to Multiple Fungicides and Dominated by a Novel Clade Closely Related to Botrytis cinereaLEROCH, Michaela ; PLESKEN, Cecilia ; WEBER, Roland W. S ; KAUFF, Frank ; SCALLIET, Gabriel ; HAHN, MatthiasApplied and Environmental Microbiology, 2013-01, Vol.79 (1), p.159-167 [Periódico revisado por pares]Washington, DC: American Society for MicrobiologyTexto completo disponível |
|
10 |
Material Type: Artigo
|
MHC proteins confer differential sensitivity to CTLA-4 and PD-1 blockade in untreated metastatic melanomaRodig, Scott J ; Gusenleitner, Daniel ; Jackson, Donald G ; Gjini, Evisa ; Giobbie-Hurder, Anita ; Jin, Chelsea ; Chang, Han ; Lovitch, Scott B ; Horak, Christine ; Weber, Jeffrey S ; Weirather, Jason L ; Wolchok, Jedd D ; Postow, Michael A ; Pavlick, Anna C ; Chesney, Jason ; Hodi, F StephenScience translational medicine, 2018-07, Vol.10 (450) [Periódico revisado por pares]United States: The American Association for the Advancement of ScienceTexto completo disponível |